In Preparation for European Partnership, Oculus Innovative Sciences Expects Expanded Label Claim for European Formulation of Dermacynâ„¢ Wound Care

[at noodls] – Upgraded Class III CE Mark to Include Claim of Potential Local Antimicrobial Effectiveness in Open Wounds PETALUMA, Calif., Dec. 24, 2012 (GLOBE NEWSWIRE) — Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) … more

View todays social media effects on OCLS

View the latest stocks trending across Twitter. Click to view dashboard

See who Oculus is hiring next, click here to view